Which has the lower trailing P/E, BIO or HSIC?

HSIC has the lower trailing P/E: BIO trades at 41.51 and HSIC at 26.66. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIO or HSIC?

Over the past five years, HSIC grew revenue faster — BIO at a 0.29% CAGR versus HSIC at 4.74%.

Is BIO or HSIC more profitable?

BIO runs the higher net margin — BIO at 8.59% versus HSIC at 2.95%.

How have BIO and HSIC total returns compared?

Over the past 10 years, BIO delivered 8.19% and HSIC delivered 3.03% annualized total return. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs Henry Schein, Inc. (HSIC)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Henry Schein, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 6, 2026. Differences are shown without an overall score or investment verdict.

BIO

Bio-Rad Laboratories, Inc.

$9.34B

$347.01HealthcareDelayed quote: Aug 7, 2026, 1:25 PM EDT

HSIC

Henry Schein, Inc.

$10.04B

$88.15HealthcareDelayed quote: Aug 7, 2026, 1:25 PM EDT

Total return — BIO vs HSIC

growth of $100 · dividends reinvested · last 30y

BIO +2182.9%HSIC +1213.8%BIO compounded faster

BIO HSIC

BIO vs HSIC: by the numbers

•HSIC is the larger company ($10.04B vs $9.34B market cap).
•HSIC trades at the lower trailing earnings multiple (26.66 vs 41.51 P/E), one valuation lens rather than an overall verdict.
•BIO converts more revenue to profit (8.59% vs 2.95% net margin).
•HSIC grew revenue faster over the past five years (4.74% vs 0.29% CAGR).

Metrics side by side

Valuation

Metric	BIO	HSIC
P/E ratio	41.51	26.66
Forward P/E	37.87	16.40
P/S ratio	3.55	0.77
P/B ratio	1.28	3.14
PEG ratio	N/A	3.23
EV / EBITDA	25.89	13.14
FCF yield	3.85%	4.21%

Profitability

Metric	BIO	HSIC
Gross margin	51.90%	29.69%
Operating margin	9.08%	5.60%
Net margin	8.59%	2.95%
ROE	3.10%	12.09%
ROIC	2.04%	6.58%

Growth (annualized)

Metric	BIO	HSIC
Revenue CAGR (5Y)	0.29%	4.74%
EPS CAGR (5Y)	-26.27%	3.14%
FCF CAGR (5Y)	-9.65%	0.82%
Total return CAGR (5Y)	-14.60%	2.75%

Frequently asked

Which has the lower trailing P/E, BIO or HSIC?: HSIC has the lower trailing P/E: BIO trades at 41.51 and HSIC at 26.66. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIO or HSIC?: Over the past five years, HSIC grew revenue faster — BIO at a 0.29% CAGR versus HSIC at 4.74%.
Is BIO or HSIC more profitable?: BIO runs the higher net margin — BIO at 8.59% versus HSIC at 2.95%.
How have BIO and HSIC total returns compared?: Over the past 10 years, BIO delivered 8.19% and HSIC delivered 3.03% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full HSIC analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio Henry Schein P/E ratio Bio-Rad Laboratories dividend yield Henry Schein dividend yield Bio-Rad Laboratories ROE Henry Schein ROE Bio-Rad Laboratories operating margin Henry Schein operating margin Bio-Rad Laboratories revenue growth Henry Schein revenue growth Bio-Rad Laboratories free cash flow Henry Schein free cash flow

Bio-Rad Laboratories & Henry Schein appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 6, 2026.